PRS13 A Budget Impact Analysis of Indacaterol for the Treatment of Chronic Obstructive Pulmonary Disease in Colombia

Value in Health ◽

10.1016/j.jval.2012.03.297 ◽

2012 ◽

Vol 15 (4) ◽

pp. A53

Author(s):

L.F. Giraldo ◽

J.G. Ariza ◽

T. Acosta ◽

J.F. Pinzon

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease

Download Full-text

Cost-effectiveness and budget impact analysis of smoking cessation interventions in chronic obstructive pulmonary disease patients in Thailand

Tobacco Induced Diseases ◽

10.18332/tid/83780 ◽

2018 ◽

Vol 16 (1) ◽

Author(s):

Ronnachai Kongsakon

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Smoking Cessation ◽

Cost Effectiveness ◽

Pulmonary Disease ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease

Download Full-text

PRS17 - BUDGET IMPACT ANALYSIS OF THE USE OF UMECLIDINIUM BROMIDE/VILANTEROL 62.5/25 MCG IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN SPAIN

Value in Health ◽

10.1016/j.jval.2018.09.2411 ◽

2018 ◽

Vol 21 ◽

pp. S406

Author(s):

L.A. Vallejo-Aparicio ◽

A. Huerta

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease

Download Full-text

BUDGET IMPACT ANALYSIS OF HOME ADVANCED NON-INVASIVE VENTILATION FOR SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Value in Health ◽

10.1016/j.jval.2016.03.690 ◽

2016 ◽

Vol 19 (3) ◽

pp. A299

Author(s):

S. Coughlin ◽

F.W. Peyerl ◽

S.H. Munson ◽

A.J. Ravindranath ◽

Jr. T.L. Lee-Chiong

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

Chronic Obstructive ◽

Invasive Ventilation ◽

Obstructive Pulmonary Disease ◽

Non Invasive ◽

Non Invasive Ventilation

Download Full-text

Budget Impact Analysis of Indacaterol/Glycopyrronium in the Treatment of Chronic Obstructive Pulmonary Disease (Copd) in Colombia

Value in Health ◽

10.1016/j.jval.2017.08.2662 ◽

2017 ◽

Vol 20 (9) ◽

pp. A888

Author(s):

A Patino ◽

E Karpf ◽

D Londoño

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease

Download Full-text

Budget Impact Analysis of Aclidinium Bromide In The Treatment of Chronic Obstructive Pulmonary Disease

Value in Health ◽

10.1016/j.jval.2016.09.1180 ◽

2016 ◽

Vol 19 (7) ◽

pp. A550

Author(s):

R Yagudina ◽

A Kulikov ◽

E Makarova

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Aclidinium Bromide

Download Full-text

PRS12 Budget Impact Analysis of Tiotropium Bromide Versus Ipratropium Bromide on the Top of Standard Therapy in the Treatment of Chronic Obstructive Pulmonary Disease (Copd) in Russian Federation

Value in Health ◽

10.1016/j.jval.2012.03.296 ◽

2012 ◽

Vol 15 (4) ◽

pp. A53

Author(s):

A. Kulikov ◽

I. Komarov

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Russian Federation ◽

Standard Therapy ◽

Ipratropium Bromide ◽

Impact Analysis ◽

Budget Impact ◽

Tiotropium Bromide ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease

Download Full-text

PRS1 BUDGET IMPACT ANALYSIS OF UMECLIDINIUM VERSUS TIOTROPIUM IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) FROM THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM PERSPECTIVE

Value in Health Regional Issues ◽

10.1016/j.vhri.2019.08.424 ◽

2019 ◽

Vol 19 ◽

pp. S77

Author(s):

D. Silva ◽

L.T.M. Saturnino ◽

M.R. Gazzotti ◽

O.A. Nascimento ◽

R. Alfonso-Cristancho

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Healthcare System ◽

Impact Analysis ◽

Budget Impact ◽

Public Healthcare ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

System Perspective ◽

Healthcare System Perspective

Download Full-text

PRS15 Estimating the Budget Impact of Introducing Indacaterol in the Treatment of Chronic Obstructive Pulmonary Disease (COPD) from the Brazilian Public Health Care System (SUS) Perspective

Value in Health ◽

10.1016/j.jval.2011.08.1402 ◽

2011 ◽

Vol 14 (7) ◽

pp. A489-A490

Author(s):

C. Suzuki ◽

N.L. Silva

Keyword(s):

Public Health ◽

Chronic Obstructive Pulmonary Disease ◽

Health Care ◽

Pulmonary Disease ◽

Health Care System ◽

Budget Impact ◽

Public Health Care ◽

Chronic Obstructive ◽

Public Health Care System ◽

Obstructive Pulmonary Disease

Download Full-text

Economic Impact of Reducing Inappropriate Inhaled Corticosteroids Use in Patients With Chronic Obstructive Pulmonary Disease: ISPOR's Guidance on Budget Impact in Practice

Value in Health ◽

10.1016/j.jval.2019.05.006 ◽

2019 ◽

Vol 22 (10) ◽

pp. 1092-1101 ◽

Author(s):

Tanja Fens ◽

Simon van der Pol ◽

Janwillem W.H. Kocks ◽

Maarten J. Postma ◽

Job F.M. van Boven

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Economic Impact ◽

Pulmonary Disease ◽

Budget Impact ◽

Inhaled Corticosteroids ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease

Download Full-text

Budget Impact of Adding a New Single Inhaler Triple Therapy (SITT) for the Treatment of Patients with Chronic Obstructive Pulmonary Disease (COPD) in the UK

Value in Health ◽

10.1016/j.jval.2018.04.1578 ◽

2018 ◽

Vol 21 ◽

pp. S232-S233

Author(s):

D Shah ◽

M Schroeder ◽

AA Martin ◽

N Risebrough ◽

K Ndirangu ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Triple Therapy ◽

Pulmonary Disease ◽

Budget Impact ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Download Full-text